Diseases associated with mutations and changes in expression of the protein caveolin may result from faulty trafficking of the protein to the cell surface.

A factor produced by most malignant cells can both promote and inhibit tumor growth – an insight that is critical to using cancer drugs developed to block this factor.

Puck Ohi, Ph.D., assistant professor of Cell and Developmental Biology, has received the Leukemia & Lymphoma Society SCHOLAR award for his research on the role of enzymes that affect cell division, which has implications for treating cancer and blood disorders like leukemia and lymphoma.

A study led by Vanderbilt University Medical Center investigators found that rates of benign lung disease diagnosis varied widely by state following surgery for lung cancer.

Jordan Berlin, M.D., professor of Medicine and Ingram Professor of Cancer Research at Vanderbilt-Ingram Cancer Center, has received the Tree of Life award from Debbie’s Dream Foundation: Curing Stomach Cancer (DDF).

David Penson, M.D., MPH, professor of Urologic Surgery, has received a $2 million research award from the Patient-Centered Outcomes Research Institute (PCORI) to study localized prostate cancer, the second leading cause of death among American men.

A high-salt diet worsens the carcinogenic effects of Helicobacter pylori, a bacterium that colonizes the stomachs of half of the world’s population.